Multiple evidence for an early age pro-oxidant state in Down Syndrome patients

Federico V. Pallardó, Paolo Degan, Marco d'ischia, Frank J. Kelly, Adriana Zatterale, Rita Calzone, Giuseppe Castello, Rafael Fernandez-Delgado, Christina Dunster, Ana Lloret, Paola Manini, Maria Antonietta Pisanti, Emilia Vuttariello, Giovanni Pagano

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Oxidative stress has been associated with Down syndrome (DS) and with its major phenotypic features, such as early ageing. In order to evaluate an in vivo pro-oxidant state, the following analytes were measured in a group of DS patients aged 2 months to 57 years: (a) leukocyte 8-hydroxy-2′-deoxyguanosine (8-OHdG); (b) blood glutathione; (c) plasma levels of: glyoxal (Glx) and methylglyoxal (MGlx); some antioxidants (uric acid, UA, ascorbic acid, AA and Vitamin E), and xanthine oxidase (XO) activity. A significant 1.5-fold increase in 8-OHdG levels was observed in 28 DS patients vs. 63 controls, with a sharper increase in DS patients aged up to 30 years. The GSSG:GSH × 100 ratio was significantly higher in young DS patients (

Original languageEnglish
Pages (from-to)211-220
Number of pages10
JournalBiogerontology
Volume7
Issue number4
DOIs
Publication statusPublished - Aug 2006

Fingerprint

Down Syndrome
Reactive Oxygen Species
Glyoxal
Pyruvaldehyde
Glutathione Disulfide
Xanthine Oxidase
Uric Acid
Vitamin E
Ascorbic Acid
Glutathione
Oxidative Stress
Leukocytes
Antioxidants

Keywords

  • 8-hydroxy-2′-deoxyguanosine
  • Down syndrome
  • Glutathione
  • Glyoxal
  • Methylglyoxal
  • Plasmaantioxidants
  • Pro-oxidant state

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Pallardó, F. V., Degan, P., d'ischia, M., Kelly, F. J., Zatterale, A., Calzone, R., ... Pagano, G. (2006). Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. Biogerontology, 7(4), 211-220. https://doi.org/10.1007/s10522-006-9002-5

Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. / Pallardó, Federico V.; Degan, Paolo; d'ischia, Marco; Kelly, Frank J.; Zatterale, Adriana; Calzone, Rita; Castello, Giuseppe; Fernandez-Delgado, Rafael; Dunster, Christina; Lloret, Ana; Manini, Paola; Pisanti, Maria Antonietta; Vuttariello, Emilia; Pagano, Giovanni.

In: Biogerontology, Vol. 7, No. 4, 08.2006, p. 211-220.

Research output: Contribution to journalArticle

Pallardó, FV, Degan, P, d'ischia, M, Kelly, FJ, Zatterale, A, Calzone, R, Castello, G, Fernandez-Delgado, R, Dunster, C, Lloret, A, Manini, P, Pisanti, MA, Vuttariello, E & Pagano, G 2006, 'Multiple evidence for an early age pro-oxidant state in Down Syndrome patients', Biogerontology, vol. 7, no. 4, pp. 211-220. https://doi.org/10.1007/s10522-006-9002-5
Pallardó, Federico V. ; Degan, Paolo ; d'ischia, Marco ; Kelly, Frank J. ; Zatterale, Adriana ; Calzone, Rita ; Castello, Giuseppe ; Fernandez-Delgado, Rafael ; Dunster, Christina ; Lloret, Ana ; Manini, Paola ; Pisanti, Maria Antonietta ; Vuttariello, Emilia ; Pagano, Giovanni. / Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. In: Biogerontology. 2006 ; Vol. 7, No. 4. pp. 211-220.
@article{fd4afed0a7ae4cd0b52ec084a91784a0,
title = "Multiple evidence for an early age pro-oxidant state in Down Syndrome patients",
abstract = "Oxidative stress has been associated with Down syndrome (DS) and with its major phenotypic features, such as early ageing. In order to evaluate an in vivo pro-oxidant state, the following analytes were measured in a group of DS patients aged 2 months to 57 years: (a) leukocyte 8-hydroxy-2′-deoxyguanosine (8-OHdG); (b) blood glutathione; (c) plasma levels of: glyoxal (Glx) and methylglyoxal (MGlx); some antioxidants (uric acid, UA, ascorbic acid, AA and Vitamin E), and xanthine oxidase (XO) activity. A significant 1.5-fold increase in 8-OHdG levels was observed in 28 DS patients vs. 63 controls, with a sharper increase in DS patients aged up to 30 years. The GSSG:GSH × 100 ratio was significantly higher in young DS patients (",
keywords = "8-hydroxy-2′-deoxyguanosine, Down syndrome, Glutathione, Glyoxal, Methylglyoxal, Plasmaantioxidants, Pro-oxidant state",
author = "Pallard{\'o}, {Federico V.} and Paolo Degan and Marco d'ischia and Kelly, {Frank J.} and Adriana Zatterale and Rita Calzone and Giuseppe Castello and Rafael Fernandez-Delgado and Christina Dunster and Ana Lloret and Paola Manini and Pisanti, {Maria Antonietta} and Emilia Vuttariello and Giovanni Pagano",
year = "2006",
month = "8",
doi = "10.1007/s10522-006-9002-5",
language = "English",
volume = "7",
pages = "211--220",
journal = "Biogerontology",
issn = "1389-5729",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Multiple evidence for an early age pro-oxidant state in Down Syndrome patients

AU - Pallardó, Federico V.

AU - Degan, Paolo

AU - d'ischia, Marco

AU - Kelly, Frank J.

AU - Zatterale, Adriana

AU - Calzone, Rita

AU - Castello, Giuseppe

AU - Fernandez-Delgado, Rafael

AU - Dunster, Christina

AU - Lloret, Ana

AU - Manini, Paola

AU - Pisanti, Maria Antonietta

AU - Vuttariello, Emilia

AU - Pagano, Giovanni

PY - 2006/8

Y1 - 2006/8

N2 - Oxidative stress has been associated with Down syndrome (DS) and with its major phenotypic features, such as early ageing. In order to evaluate an in vivo pro-oxidant state, the following analytes were measured in a group of DS patients aged 2 months to 57 years: (a) leukocyte 8-hydroxy-2′-deoxyguanosine (8-OHdG); (b) blood glutathione; (c) plasma levels of: glyoxal (Glx) and methylglyoxal (MGlx); some antioxidants (uric acid, UA, ascorbic acid, AA and Vitamin E), and xanthine oxidase (XO) activity. A significant 1.5-fold increase in 8-OHdG levels was observed in 28 DS patients vs. 63 controls, with a sharper increase in DS patients aged up to 30 years. The GSSG:GSH × 100 ratio was significantly higher in young DS patients (

AB - Oxidative stress has been associated with Down syndrome (DS) and with its major phenotypic features, such as early ageing. In order to evaluate an in vivo pro-oxidant state, the following analytes were measured in a group of DS patients aged 2 months to 57 years: (a) leukocyte 8-hydroxy-2′-deoxyguanosine (8-OHdG); (b) blood glutathione; (c) plasma levels of: glyoxal (Glx) and methylglyoxal (MGlx); some antioxidants (uric acid, UA, ascorbic acid, AA and Vitamin E), and xanthine oxidase (XO) activity. A significant 1.5-fold increase in 8-OHdG levels was observed in 28 DS patients vs. 63 controls, with a sharper increase in DS patients aged up to 30 years. The GSSG:GSH × 100 ratio was significantly higher in young DS patients (

KW - 8-hydroxy-2′-deoxyguanosine

KW - Down syndrome

KW - Glutathione

KW - Glyoxal

KW - Methylglyoxal

KW - Plasmaantioxidants

KW - Pro-oxidant state

UR - http://www.scopus.com/inward/record.url?scp=33747256270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747256270&partnerID=8YFLogxK

U2 - 10.1007/s10522-006-9002-5

DO - 10.1007/s10522-006-9002-5

M3 - Article

VL - 7

SP - 211

EP - 220

JO - Biogerontology

JF - Biogerontology

SN - 1389-5729

IS - 4

ER -